We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Regular ECG May Help Identify Patients at Risk of Sudden Cardiac Death

By HospiMedica International staff writers
Posted on 17 Sep 2009
QRS duration (QRSd)--one of several measures of heart function recorded during a routine electrocardiogram (ECG)--has been found to be a significant predictor of sudden cardiac death, according to a new study.

Researchers from New York-Presbyterian Hospital/Weill Cornell Medical Center (New York, NY, USA) and the Ochsner Clinic Foundation (New Orleans, LA, USA) analyzed data drawn from a large, multicenter study of patients with hypertension (conducted between 1995 and 2001) that was initially designed to test the comparative effects of two medications on patients' blood pressure and overall cardiovascular health. More...
The authors of the new statistical study looked at some of these data from the LIFE study and investigated a possible association between prolonged QRSd and the risk of sudden cardiac death.

The researchers were able to isolate and control potential confounders such as left bundle branch block (LBBB), and also controlled for abnormal enlargement of the left ventricle, known as left ventricle hypertrophy (LVH), another common cardiac abnormality associated with sudden cardiac death. Once these variables were controlled, a clear link between abnormal QRSd and the risk of sudden death emerged. The study was published in the August 17, 2009, online edition of the European Heart Journal.

"Because an ECG is a routine part of every patient's annual physical exam, physicians can easily track it and take note of any change,” said senior author Prof. Peter Okin, M.D. "If QRSd increases, it suggests an increased risk of sudden cardiac death--and that additional evaluation and treatment may be indicated. What we hope is that physicians will start paying more attention to QRSd as a warning signal. If they do, lives could be saved.”

Sudden cardiac death (SCD) accounts for more than half of all deaths from cardiovascular disease. It is defined as unexpected death within 24 hours of cardiac symptoms, including those that cannot be traced to an identifiable cause, such as long-term congestive heart failure (CHF).

Related Links:
New York-Presbyterian Hospital/Weill Cornell Medical Center
Ochsner Clinic Foundation


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.